Rick Simpson Oil (RSO) in Miami County, Kansas: The Complete Guide by OilWell Cannabis

If you’re reading this in Miami County, Kansas — whether you’re in Paola, Osawatomie, Louisburg, or out in the rural townships between them — you’re likely here because conventional medicine hasn’t delivered the relief you need. Maybe it’s chronic pain that keeps you from working the fields or taking care of your property. Maybe it’s cancer treatment side effects that leave you searching for alternatives. Maybe it’s PTSD from military service that’s worn you down, or a loved one’s condition that has you up at night researching every possible option. We understand. OilWell Cannabis didn’t start in a corporate boardroom. We started with a dog named Bentley, a man named Colin who grew up in the borderlands of McAllen, Texas, and a refusal to give up on the people who depend on us.

Miami County has a population of about 34,000 spread across 590 square miles of Kansas prairie. You know your neighbors. You know the value of hard work. You also know that when the nearest oncologist is an hour away in Overland Park, and the pain clinic in Kansas City has a three-month wait, you need real information and real options. That’s what this guide delivers. We’re a Houston-based cannabis company reaching out to Miami County because we’ve built something that Kansas law allows and Kansas residents need: legal, lab-tested, multi-cannabinoid Rick Simpson Oil that ships directly to your door.

Rick Simpson Oil is the most searched cannabis extract term in the world. But most of what you’ll find online is mythology built on half-truths. We respect Rick Simpson’s historical contribution — he gave his oil away for free and helped create the modern cannabis movement — but we also know he wasn’t a doctor, never ran a clinical trial, and his original protocol had real safety risks . This guide gives you what no other RSO resource does: the complete history, the unfiltered science, our exact formulas (so you can make it yourself if you need to), and honest guidance on what works, what doesn’t, and what’s still emerging.

Who Was Rick Simpson and What Is Traditional RSO?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a medical professional. He was a power engineer and maintenance worker — a blue-collar tradesman whose journey into cannabis began when the medical system failed him . In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from scaffolding and suffered a serious head injury. The medications he was prescribed either didn’t help or made things worse. When he found cannabis gave him more relief than anything his doctors offered, his physician refused to support it .

Simpson’s interest in concentrated cannabis oil deepened after learning about a 1974 NIH study at the Medical College of Virginia that suggested THC might shrink tumors in mice . That study was never replicated in controlled human trials — a critical detail — but it became the spark for Simpson’s advocacy.

The pivotal moment came in 2003. Simpson reported that three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursue conventional treatment, he applied concentrated cannabis oil directly to them. According to his account, the bumps disappeared within four days . Important context: No independent medical verification, biopsy confirmation, or peer-reviewed documentation of this outcome exists. Simpson’s account is personal testimony, not medical evidence, though it became historically significant as the catalyst for a global movement .

After 2003, Simpson committed himself to producing oil and giving it away for free to cancer patients and others in his community. He claimed to help people with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and many other conditions . His story reached millions through the 2005 documentary Run From The Cure, which he distributed freely online .

But his advocacy brought legal conflict. The Royal Canadian Mounted Police raided his property in 2005 and 2009. He was charged with cultivation, possession, and trafficking. Eventually, he left Canada and continued his advocacy from Europe. In 2012, he published Phoenix Tears: The Rick Simpson Story and maintained phoenixtears.ca as his information platform .

Simpson remained uncompromising: he insisted RSO could cure cancer and that pharmaceutical companies and government agencies were suppressing this knowledge . Important context: Simpson’s conspiratorial framing is noted without endorsement. It reflects a worldview shared by many in the early cannabis movement, but the evidence evaluation that follows applies modern scientific standards.

The Traditional RSO Protocol: Simpson’s 60-Gram Regimen

Simpson recommended consuming 60 grams of concentrated cannabis oil over approximately 90 days. Here’s exactly what that entailed :

Week 1: Start with a dose the size of half a grain of rice — about 10-15 mg of oil — taken three times daily. Total daily intake: 30-45 mg.

Weeks 2-5: Double the dose every four days. The target by week five: 1 gram (1,000 mg) of oil per day, divided into three doses.

Weeks 5-12: Maintain 1 gram per day (333 mg per dose) until all 60 grams are consumed.

Administration: Primary method was sublingual or oral ingestion. For skin cancers, topical application with bandages. Inhalation was acknowledged for immediate symptom relief but not as primary treatment .

Tolerance: Simpson claimed patients develop THC tolerance within 3-4 weeks and recommended nighttime dosing initially to sleep through the psychoactive effects. He warned against driving during titration .

Post-protocol maintenance: After completing 60 grams, Simpson recommended 1-2 grams per month indefinitely .

Diet: He suggested reducing sugar and processed foods, though this was secondary to the oil protocol .

Critical Context: Evaluating Simpson’s Protocol

This protocol was designed by one person based on personal experience. Several critical points apply:

• No controlled trial validation. There are no published randomized controlled trials, cohort studies, or well-documented case series evaluating this 60-gram/90-day protocol for any condition .
• Crude, unstandardized material. The 60-gram quantity assumes a single-strain, THC-dominant extract with no standardized potency. Traditional RSO potency varied widely .
• Very high THC exposure. At peak dosing (1 gram per day of 60-90% THC oil), patients consumed 600-900 mg of delta-9 THC daily. FDA-approved dronabinol is typically dosed at 2.5-20 mg per day [13].
• Real risks at these doses: Severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder are well-documented at high THC doses [1][13][14][15].
• Oncology complexity: Patients with active cancer are medically complex. Using unregulated, unstandardized cannabis oil as primary treatment — potentially in place of proven therapies — introduces harm beyond the oil itself .

Traditional RSO As a Product: What It Actually Was

Source material: Single high-THC indica strain, no standardization. Every batch differed based on plant genetics and growing conditions .

Extraction solvent: Naphtha (petroleum-based) or 99% isopropyl alcohol. Neither is food-grade. Naphtha may contain benzene, toluene, and other carcinogens. Incomplete solvent purging is difficult to verify without lab testing .

Process: Plant material in a bucket, covered with solvent, agitated, filtered, evaporated in a rice cooker at temperatures that decarboxylated all THCa into THC and destroyed terpenes. Resulting oil transferred to syringes .

Appearance: Nearly black, thick, tar-like, with strong cannabis odor and possible solvent-residual smell .

Cannabinoid profile: THC-dominant (60-90% estimated), fully decarboxylated. Minor cannabinoids present at natural, uncontrolled ratios. No lab verification .

Terpene content: Minimal to none. The solvent + heat process destroyed volatile terpenes .

Standardization: None. No Certificate of Analysis, no potency testing, no contaminant screening .

Residual solvent risk: Naphtha and isopropyl alcohol carry significant toxicity risks if not fully purged. Modern extraction uses food-grade ethanol or CO₂ to address this .

Simpson’s Claims vs. The Evidence Record

Simpson claimed RSO could cure cancer and many other diseases. Let’s evaluate this against actual evidence.

What Simpson was not: Not a scientist, physician, pharmacologist, or researcher. No formal training. Never conducted or published a clinical trial. His evidence base was personal experience and testimonials .

What preclinical literature shows: THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines. Animal studies show some tumor-growth inhibition . These findings generate scientific interest but have not translated into proven human cancer cures.

What preclinical literature does NOT show: The gap between in vitro/animal results and human outcomes is vast. No human clinical trial has demonstrated RSO cures cancer . Several small human trials of cannabinoids in cancer contexts (especially glioblastoma) have been exploratory, small, and have not produced cancer-cure results .

Institutional positions:

• NCI acknowledges cannabinoid anticancer research in lab and animal models but does not endorse cannabis as cancer treatment .
• FDA has not approved any cannabis plant product for cancer. Only Epidiolex (CBD for seizures) and synthetic THC analogues for chemo nausea and AIDS wasting are approved [1].
• Health Canada has never approved RSO for cancer .
• NCCIH states strongest evidence is for rare epilepsies, chemo nausea, and HIV/AIDS appetite — not cancer cure [1].

What Simpson got right: He drew attention to cannabinoids as serious biomedical research when the world ignored it. He helped create conditions for the legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract .

What he overstated: Cure claims exceeded evidence. Encouraging patients to use RSO instead of proven cancer therapies carries genuine harm potential. Delayed or foregone treatment is a documented concern .

Traditional RSO vs. Modern Formulated RSO

The table below shows how OilWell’s approach differs from what Rick Simpson originally made.

Dimension	Traditional RSO	OilWell RSO for Miami County
Source material	Single high-THC indica strain	Multi-cannabinoid blend from multiple hemp sources
Extraction method	Naphtha or isopropyl alcohol	Modern food-grade ethanol (no solvents in final product)
Cannabinoid profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios (16,590 mg total)
Terpene content	Destroyed by high-heat process	Live terpenes at 5% with seven defined terpenes
Standardization	None — every batch different	Lab-tested with specific mg/mL targets (553 mg/mL)
Lab testing	Not performed	Full panel: potency, terpenes, pesticides, heavy metals, residual solvents, microbial
Residual solvents	Significant risk with naphtha	None — solvent-free production
Dosing precision	Approximate, syringe-based	Measured per mL with graduated dropper (0.1 mL increments)
Product formats	One thick oil only	Sublingual oil AND vape cartridge with format-specific formulas
THCa preservation	No — fully decarboxylated by heat	Yes — 1,500 mg THCa included as separate ingredient
Legal status	Schedule I (illegal)	Farm Bill compliant (less than 0.3% delta-9 THC)
Evidence approach	Anecdotal, personal testimony	Research-backed, evidence-weighted with 29 peer-reviewed citations

Why Our Formulas Diverge from Traditional RSO

Our RSO is informed by Rick Simpson’s tradition but deliberately different in five evidence-motivated ways:

1. Multi-cannabinoid approach. Traditional RSO relied on whatever single strain was available. Our formula includes seven cannabinoids — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — because entourage-effect literature suggests potential benefit from cannabinoid diversity [20][29].

2. Terpene preservation and addition. Traditional RSO had essentially no terpenes. We include live terpenes at 5% with a specific seven-terpene profile — limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene — because terpene bioactivity is plausible and supported at preclinical levels [20]-[29].

3. THCa as a separate ingredient. Traditional RSO fully decarboxylated everything. Our sublingual formula includes 1,500 mg THCa as distinct ingredient, preserving the acidic precursor because THCa literature suggests potentially relevant non-psychoactive bioactivity (COX-2 inhibition, PPARγ agonism) that is lost when THCa converts to THC [12].

4. Reduced delta-9 THC dominance. Traditional RSO was 60-90% delta-9 THC. Our sublingual formula uses only 90 mg delta-9 THC total, distributing the remaining cannabinoids across CBD (4,500 mg), CBG (3,000 mg), delta-8 THC (6,000 mg), CBN (750 mg), and CBC (750 mg). This reflects broader cannabinoid research rather than single-compound dominance.

5. Product format innovation. Simpson envisioned only oral oil from a syringe. We offer both a 30 mL sublingual oil and a 1-gram vape cartridge, each with format-specific formulation acknowledging that different delivery routes have different pharmacokinetic profiles (onset, peak, duration) [14].

Solvent Safety: Why It Matters for Miami County

Traditional RSO used naphtha or isopropyl alcohol — neither food-grade. Naphtha contains benzene, toluene, and other carcinogens. Incomplete solvent purging leaves toxic residues impossible to verify without lab equipment.

Modern cannabis extraction uses food-grade ethanol or supercritical CO₂, allowing complete solvent removal verified by headspace gas chromatography. Our RSO is not an extraction product — it’s a formulated blend of individual cannabinoid distillates combined in controlled production. No naphtha. No alcohol. No butane.

We use organic MCT oil as carrier — food-grade, facilitates sublingual absorption, and provides neutral taste. This is a major improvement over traditional RSO’s tar-like consistency and solvent-residual odor.

Third-party lab testing covers potency, terpenes, pesticides, heavy metals, residual solvents, and microbial contaminants. COAs are available on request and through our website. For Miami County residents, this level of testing matters — you can’t afford to guess what’s in your medicine when the nearest ER is 40 miles away.

The Decarboxylation Choice: Patient-Controlled Potency — A Game-Changer for Kansas

Traditional RSO was always fully decarboxylated (activated THC). Our sublingual formula contains 1,500 mg THCa in its acidic, non-psychoactive form. This creates three distinct usage options:

Option 1 — Raw, no heat. All 1,500 mg stays as THCa — completely non-psychoactive. Suitable for daytime use, work, driving, and functioning with zero impairment. This addresses a major concern for Miami County’s workforce — you can use RSO without failing to show up for your responsibilities.

Option 2 — Fully activated, home decarboxylation. Heat the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. This converts 1,500 mg THCa into approximately 1,315 mg delta-9 THC. Combined with the existing 90 mg delta-9 THC, you get ~1,405 mg total delta-9 THC. Plus 6,000 mg delta-8 THC. This delivers psychoactive potency comparable to traditional illegal RSO — 100% legally, because decarboxylation occurs after purchase at your discretion.

Option 3 — Vape, auto-decarboxylation. Our vape cartridge operates at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Every inhalation delivers freshly activated cannabinoids — fastest onset available.

Partial decarboxylation: You can transfer a controlled portion from the original bottle into a second oven-safe container, decarboxylating only what you intend to use while preserving the remainder in raw THCa form.

This patient-controlled approach aligns with Rick Simpson’s principle that patients should control their medicine, but we implement it through chemistry rather than rhetoric. For Miami County residents facing chronic pain while needing to stay functional for farm work or factory shifts, this flexibility is invaluable.

The OilWell Story: From Bentley’s Ball to Serving Kansas

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But our story begins not in Texas, but in McAllen — a border city in the Rio Grande Valley where Colin grew up directly across from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa Borderplex is one of the most economically challenged and dangerous regions along the entire U.S.-Mexico border. McAllen has vibrant culture but limited opportunities outside retail and healthcare. Reynosa, an industrial hub, is plagued by cartel violence. Growing up there teaches you about survival, about community, and about looking for solutions when the system fails you.

Colin’s childhood was marked by exposure to both opportunity and danger. By his early teens, he was transporting items across the border for various groups. Many of his best friends have been killed or are imprisoned because of those associated dangers. He faced every form of violence imaginable, both in the streets and across the border. By sixteen, he had to leave home for good.

Despite the dangers, Colin chose cannabis over darker paths. He grew up in the traditional cannabis world pre-legalization, learning the plant intimately while operating in the shadows. Over time, he transitioned from those risky ventures to creating a legal, legitimate business.

Later, Colin became a formally trained software engineer and did custom development work for Baylor College of Medicine in the Texas Medical Center — one of the most prestigious medical institutions in the country. That combination — deep cannabis plant knowledge plus medical-grade technical precision — defines how we build every product today.

Bentley: The Dog Who Started Everything

The company’s origin story begins with a dog named Bentley. Bentley was family, a companion who stood by Colin through the toughest times. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants to hear: euthanasia was the only humane option. Bentley was paralyzed in his back legs. They said pain medications would destroy his internal organs, causing more suffering. The choice was prolonged decline or immediate mercy killing.

But giving up on Bentley was not an option. In a desperate search for alternatives, Colin stumbled upon CBD through a question that changed everything. A rescue worker named Jessica asked: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin had cannabis experience, but it was recreational — getting high. He’d never explored therapeutic applications. Jessica’s question exposed a blind spot that became a mission.

Determined to save Bentley, Colin learned to create CBD golden paste — a specialized cannabinoid formula for pets. It wasn’t a cure, but it was a lifeline. And that hope delivered something veterinary medicine said was impossible: Bentley got up, walked over, and brought his ball to play. From paralyzed to playing fetch. This was not placebo — dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced. Neurodegeneration led him to understand CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection [7][8][12]. Dementia led him to CBC’s role in neurogenesis [18][19]. Glaucoma led him to THC’s CB1 agonism for intraocular pressure [13]. Crippling arthritis led him to develop multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene targeting different receptor systems simultaneously [4][12][24].

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. CBD alone couldn’t address neurodegeneration, dementia, glaucoma, and arthritis simultaneously. Minor cannabinoids became critical as Bentley aged. Pharmaceutical precision mattered — Bentley’s life depended on formula accuracy, not guesswork.

This is why our RSO contains seven cannabinoids. It wasn’t a marketing decision. It was born from necessity — a decade of watching a loved one decline and refusing to accept that “there’s nothing more we can do.”

Colin’s Personal Battle: PTSD and Benzo Addiction

Colin also knows pharmaceutical dependence personally. He struggled with severe PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey — notoriously difficult and dangerous — using the cannabinoid knowledge he developed keeping Bentley alive.

The Peace Gummies formula that became an OilWell product was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, we also offer Peace Gummies in vape form, which Colin personally uses to manage his insomnia and severe PTSD on an ongoing basis. This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

Over time, the therapeutic benefits Colin first discovered through Bentley became the core of his work. He has developed formulas that doctors use for Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

ABC13 Houston: Seven Features, Five Reporters, Four Years

Between September 2019 and April 2023, ABC13 Houston — the ABC affiliate serving America’s fourth-largest city — featured Colin and OilWell Cannabis in seven distinct news segments. Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers sought us out for coverage spanning business, law, medicine, community health, and politics.

Why does Houston media matter for Miami County, Kansas? Because when a major-market ABC affiliate repeatedly selects the same cannabis operator as its primary expert across four years, that’s independent validation you can’t buy. We’re not asking you to trust our marketing. We’re asking you to trust what Houston’s number-one news source documented.

September 15, 2019: CBD Business Boom

Reporter Tom Abrahams interviewed Colin as Texas’s CBD industry exploded post-Farm Bill. The feature included our foundational philosophy:

“I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.” — Colin Valencia

That quote — from 2019, years before we published our formulas — is the seed of everything we became. The open-source formula publication, the evidence-based documentation, the refusal to make unsupported claims: it all traces back to this principle.

March 22, 2021: Direct-to-Consumer Business

Tom Abrahams returned to cover decriminalization efforts and Jonathan Pina’s mobile vendor concept. Colin explained the deeper therapeutic dimension:

“People think that everyone just wants to get high and it’s about giggling and things like that, and there’s nothing wrong with that. But that’s a different version of therapy, and people are looking for things to help them with real pain. Pain comes in a lot of different forms.”

May 24, 2021: Delta-8 THC Investigation

Steve Campion’s investigative feature on Delta-8 became one of ABC13’s most referenced cannabis segments. The exchange captured Colin’s radical honesty:

Steve Campion: “Why would someone want to smoke that?”

Colin Valencia: “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high.”

The piece balanced our stance with Dr. Michael Weaver’s medical caution and Heather Fazio’s regulatory advocacy from Texans for Responsible Marijuana Policy. The full DEA statement documented federal ambiguity [10].

August 20, 2021: COVID Vaccine Giveaway

We gave away 1,000 special edition caviar pre-rolls (valued at ~$35,000) to encourage COVID-19 vaccination. We coordinated with the City of Houston, hosted the giveaway at HydroShack Hydroponics in The Heights, and posted on Instagram:

“We just want Houston to be as healthy as possible. We’re not doctors. We’re not experts on this . We don’t have any political agenda. Come and participate if it’s right and safe for you and your loved ones!”

This wasn’t marketing. It was documented community health action during a crisis.

October 19, 2021: Delta-8 Ban Impact

Shelley Childers found that Colin had already removed all Delta-8 products from shelves before enforcement began — proactive ethical action when Texas DSHS reclassified Delta-8 as Schedule I overnight. We tried to warn other operators who were unknowingly shipping Schedule I narcotics. Zachary Maxwell of Texas Hemp Growers provided context: veterans with PTSD, $50 million Texas market, felony penalties for a single vape cartridge.

“So those people are now, because they didn’t know, shipping Schedule I narcotics, and people are receiving it.” — Colin Valencia

October 7, 2022: Biden Marijuana Pardon

Nick Natario’s feature revealed Colin’s personal marijuana conviction history — the most personal revelation in our media record. It transforms every prior feature: this is someone who has lived the consequences of cannabis criminalization.

“You face challenges with housing, loans, and banking, I mean with about everything.” — Colin Valencia

“I would love to see people not get hurt for this anymore.” — Colin Valencia

The political context (300,000 state arrests vs. 6,500 pardons, Abbott vs. O’Rourke) highlighted Texas’s resistance to reform while we debuted our CBD vending machine.

April 21, 2023: 4/20 Special

Nick Natario’s most recent feature showed Colin growing hemp on camera and explaining the “Renaissance” moment:

“Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.” — Colin Valencia

Nico Richardson of Texas Original compared Texas (10,000 active medical patients) to Florida (700,000 patients despite two-thirds the population), and Mark Jones of Rice University explained why full legalization wouldn’t happen in 2023.

Complete Quote Index: Consistency Across Four Years

These 13 quotes, preserved exactly as aired, demonstrate that Colin has said the same things publicly for years — not pivoting with trends.

1. “I’m not trying to sell people snake oil…” (Sept 2019)
2. “Pain comes in a lot of different forms.” (Mar 2021)
3. “Maybe you want to get high.” (May 2021)
   4-5. “We just want Houston to be as healthy as possible…” and “trying to get the city behind me…” (Aug 2021)
   6-9. “It’s going to be a surprise…”, “It was a prime seller…”, “those people are now… shipping Schedule I narcotics…”, “It’s disappointing, but I’m not going to lose my customers…” (Oct 2021)
   10-11. “You face challenges with housing, loans, and banking…” and “I would love to see people not get hurt for this anymore.” (Oct 2022)
   12-13. “I want it to be legalized…” and “Right now is actually a pretty – like Renaissance – pretty important time…” (Apr 2023)

Media-verified operational facts:

• OilWell Cannabis operates from 810 Richmond Avenue, Houston, TX 77006 (Montrose neighborhood)
• Operating since 2019, ~$1M annual revenue, near-5.0 Google rating
• Texas DSHS licensed
• Products sold at HydroShack Hydroponics on West 20th Street in The Heights
• Partnership with The Game on Delta-8 caviar comet rock pre-rolls
• CBD vending machine innovation debuted in 2022

These features cannot be purchased. They are earned recognition from a major-market news organization that repeatedly identified Colin as Houston’s most credible cannabis voice. For Miami County residents evaluating whether to trust a Texas company, this media record provides third-party validation no marketing copy can replicate.

The Science: What We Know and What We Don’t

Research Method and Evidence Weighting

This guide prioritizes evidence in strict hierarchy: human clinical trials, systematic reviews, institutional summaries (NIH/NCCIH), then preclinical/mechanistic literature when human data is sparse [1]-[29]. The evidence base is not evenly distributed. CBD and delta-9 THC have the strongest human data; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes rely more on reviews, animal work, and pharmacology [1]-[29].

Institutional Baseline from NIH and NCCIH

The National Center for Complementary and Integrative Health states that the strongest established cannabinoid evidence is for certain rare epilepsies (Epidiolex), chemotherapy-related nausea/vomiting, and appetite/weight loss in HIV/AIDS [1]. For chronic pain and multiple sclerosis symptoms, evidence is modest. Many claimed uses remain early-stage or unproven [1].

The FDA has not approved the cannabis plant itself for medical use. Only purified CBD (Epidiolex) and synthetic THC-like drugs (dronabinol, nabilone) have specific approvals [1].

Safety concerns consistently highlighted include impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, accidental pediatric exposure, contamination, and labeling inaccuracy [1]. For Miami County residents who may be driving long distances on rural roads or operating farm equipment, these risks require honest discussion.

Cannabinoid Profiles: Evidence for Each Compound in Our Formula

CBD (4,500 mg in sublingual formula, 30% in vape)

CBD has the strongest human evidence in our formula set, especially as purified product rather than wellness ingredient [1]-[6].

Best supported: Purified CBD for seizure disorders (Epidiolex) is the clearest major indication acknowledged by institutional literature [1][2].

Anxiety: A 2024 systematic review and meta-analysis of 316 participants across eight studies reported significant anxiolytic signal, but authors stressed the clinical sample remains limited and more trials are needed [3].

Pain: A 2024 systematic review concluded the pain literature is promising but heterogeneous, with trial quality limiting broad analgesic claims [4].

Sleep: A 2023 insomnia review found literature methodologically weak, with few objective sleep assessments [5].

Safety: A 2023 systematic review found real signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy [6]. NCCIH separately flags diarrhea, sleepiness, appetite changes, mood effects, liver abnormalities, and drug interactions [1].

For Miami County: If you’re taking pain medications, antidepressants, or other prescriptions, CBD’s interaction potential means you should consult your healthcare provider before adding RSO.

CBG (3,000 mg in sublingual formula, 20% in vape)

Evidence profile: Mostly review-level and preclinical; human evidence sparse [7][8].

Pharmacology: CBG is the biosynthetic precursor to several cannabinoids and appears pharmacologically distinct from THC and CBD. Review literature describes interactions with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A signaling, making it mechanistically interesting but not clinically established [7].

Research areas: Reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity, but these are pharmacology-led hypotheses or preclinical findings [7][8].

Caution: A 2021 review explicitly notes CBG is being sold commercially while the evidence base remains thin [7].

For Miami County: CBG shows promise for inflammation and gut health, but it’s not yet a proven therapy. We include it because the preclinical signal is strong enough to justify inclusion while we await more human data.

Delta-8 THC (6,000 mg in sublingual formula, 15% in vape)

Evidence profile: Pharmacologically relevant, psychoactive, and much less clinically characterized than delta-9 THC [9]-[11].

Comparative pharmacology: A 2022 review concluded delta-8 THC and delta-9 THC have broadly similar pharmacokinetic behavior. Delta-8 is a partial CB1 agonist with cannabimimetic activity in animals and humans, but appears less potent than delta-9 THC [9].

Public health: A 2023 scoping review found the evidence base dominated by animal studies, product chemistry, and use reports, with reports of adverse consequences and emphasis on regulatory concerns [10].

Manufacturing: Commercial delta-8 interest is tied to greater stability and easier synthesis relative to naturally scarce plant levels, which raises product-byproduct and lab-testing questions [11].

Bottom line: Delta-8 THC is a psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, and more manufacturing-quality uncertainty than many consumers realize [9]-[11].

For Miami County: Delta-8 THC provides therapeutic THC-like effects with potentially reduced psychoactive intensity compared to delta-9 THC. For pain patients who need relief without overwhelming impairment, this matters.

THCa (1,500 mg in sublingual formula, 10% in vape)

Evidence profile: Important chemically but low on direct human therapeutic evidence [12].

What it is: THCa is the acidic precursor of THC and may represent large share of THC-related content in raw plant material. Storage and heating can convert THCa to THC [12].

Psychoactivity: THCa itself does not produce psychoactive effects associated with THC, but only if the molecule stays acidic and is not substantially decarboxylated [12].

Research status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but these are not established human outcomes [12].

For Miami County: THCa gives you control. Use it raw for non-psychoactive anti-inflammatory effects during the workday. Decarboxylate it at home for full psychoactive potency when you need maximum relief. No other RSO product offers this flexibility.

Delta-9 THC (90 mg in sublingual formula, minimal in vape)

Evidence profile: Strongest human evidence of psychoactive cannabinoids, but also clearest adverse-effect burden [1][13]-[15].

Institutionally supported: NCCIH identifies THC-containing medicines as relevant for chemotherapy-related nausea/vomiting, appetite/weight loss in HIV/AIDS, and some MS/pain outcomes [1].

Pain evidence: A 2022 systematic review found high-THC products may provide short-term pain benefit but also increased dizziness, sedation, nausea, and treatment discontinuation [13].

Pharmacokinetics: Inhaled THC: effects within seconds-minutes, peak 15-30 minutes, duration a few hours. Oral THC: later onset, later peak, longer duration [14].

Mental health risk: A 2025 systematic review found consistent unfavorable associations between high-concentration THC products and psychosis/schizophrenia outcomes, cannabis use disorder, anxiety, and depression [15].

Safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency potential, withdrawal, pregnancy concerns, accidental pediatric exposure, vape lung injury concerns [1][14][15].

For Miami County: Our formula contains only 90 mg delta-9 THC total (3 mg/mL) — dramatically less than traditional RSO. We focus on delta-8 THC and other cannabinoids to provide therapeutic effects with potentially lower psychiatric risk.

CBN (750 mg in sublingual formula, 10% in vape)

Evidence profile: Weak human evidence; marketing moved ahead of data [12][16][17].

Sleep claims: A 2021 narrative review screened 99 human-study abstracts and reviewed eight full-text articles, finding no clinical trials using validated sleep questionnaires or polysomnography to substantiate strong sleep-promoting claims [16].

Broader sleep literature: A 2024 updated review concluded overall cannabinoid sleep research doesn’t match real-world use scale, and need for better-designed trials remains substantial [17].

THCa degradation: THC can degrade toward CBN under certain conditions, explaining why CBN is often discussed in aging/oxidized cannabis chemistry [12].

For Miami County: CBN’s reputation as “the sleep cannabinoid” is widespread, but evidence is limited. We include 750 mg (25 mg/mL at full dose) because some users report sleep benefits, but we won’t overstate what science supports [16][17].

CBC (750 mg in sublingual formula, 10% in vape)

Evidence profile: Emerging, intriguing, overwhelmingly preclinical [18][19].

Pharmacology: A 2024 review argues CBC has distinct pharmacodynamics and receptor behavior, highlighting antinociceptive, antibacterial, and anti-seizure areas as especially interesting research targets [18].

Older literature: Review of animal/in vitro work reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesia, and possible neurobiological/antiproliferative relevance, but not yet strong patient-facing evidence [19].

Safety caveat: The 2024 CBC review explicitly notes over-the-counter CBC products are being sold despite little evidence establishing clinical efficacy or safety [18].

For Miami County: CBC is in the “scientifically credible but needs more research” category. We include it for potential neuroprotective and anti-inflammatory synergy, but make no claims beyond what’s supported [18][19].

Terpene Profiles: The Science of Aroma and Effect

Terpene claims need stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. Robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene (citrus-bright aroma)

Evidence: Largely review and preclinical, with safety literature [20]-[22].

Potential activity: A 2021 review describes antioxidant, anti-inflammatory, cardioprotective, gastroprotective, and immune-modulatory possibilities, but most claims come from nonhuman or non-cannabis literature [21].

Safety note: Limonene oxidation products (hydroperoxides) are clinically relevant contact allergens important in dermatology patch-testing [22].

For Miami County: Limonene contributes bright, uplifting aroma and may support mood, but cannabis-specific therapeutic claims should stay conservative [20]-[22].

Myrcene

Evidence: Mostly preclinical, very limited human data [20][23].

Research: A 2021 review describes anxiolytic, antioxidant, anti-inflammatory, and analgesic properties, but explicitly states human studies are lacking [23].

Interpretation caution: Myrcene is popularly claimed to be sedating and responsible for “couch-lock,” but this is stronger than human evidence supports [20][23].

For Miami County: Myrcene may contribute to relaxation, but strong sedation claims are ahead of the data [23].

Caryophyllene (pepper/spice aroma)

Evidence: Among most mechanistically interesting terpenes due to direct cannabinoid system relevance, but still preclinical [24].

Why it stands out: A 2021 review describes beta-caryophyllene as a selective CB2 receptor agonist — unusual for a terpene and especially relevant pharmacologically [24].

Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective actions discussed, but human clinical confirmation limited [24].

For Miami County: Caryophyllene is arguably the strongest candidate for terpene-cannabinoid synergy via CB2 activation, but still should not be described as clinically proven [24].

Pinene (forest-fresh aroma)

Evidence: Promising preclinical literature, weak human confirmation [20][25].

Brain-health framing: A 2021 review found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized lack of well-designed clinical trials [25].

Interpretation caution: Claims that pinene improves memory, sharpens attention, or counterbalances THC cognitive effects remain hypotheses, not settled facts [20][25].

For Miami County: Pinene’s piney aroma connects to Kansas’s state identity (Pinus strobus, Eastern White Pine), but cognition claims are exploratory [25].

Linalool (floral, lavender aroma)

Evidence: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26].

Research: A 2021 brain-health review found enough preclinical signal to justify continued neurological/psychiatric investigation, while stressing lack of robust human trials [25]. Other literature discusses possible antidepressant mechanisms [26].

Safety: Oxidized linalool hydroperoxides are recognized allergens in dermatitis literature [22].

For Miami County: Lavender is familiar to many Kansas households. Linalool may support calm and stress relief, but therapeutic claims should be cautious [25][26].

Humulene (earthy, woody aroma)

Evidence: Translationally interesting, early-stage [20][27].

Scoping review: A 2024 review analyzed 340 articles, finding broad preclinical evidence for anti-inflammatory effects, with some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27].

Interpretation caution: Findings are valuable for hypothesis generation but don’t yet establish consistent human efficacy across pain, inflammation, or mood outcomes [27].

For Miami County: Humulene’s earthy profile complements Kansas’s agricultural heritage, but clinical claims should be conservative [27].

Terpinolene (piney, fruity, sparkling aroma)

Evidence: One of least clinically characterized terpenes in this file [20][28].

Systematic review: A 2021 review screened 2,449 records, included 57 studies, concluding the evidence base is dominated by in silico, in vitro, and animal studies rather than human trials [28].

For Miami County: Terpinolene adds complexity to the aroma profile, but among listed terpenes, it remains especially underdeveloped clinically [28].

Research Limits and How to Interpret Them

• The evidence base is highly uneven. CBD and delta-9 THC support the most detailed human-facing statements; the rest require more caution [1]-[29].
• Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, and terpene-only data are not interchangeable. A common error is letting evidence from one category stand in for another.
• Minor cannabinoids and terpenes are commercially interesting precisely because they’re underexplored, but that means claims often become inflated.
• Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, and route-dependent pharmacokinetics all affect real-world interpretation [1][10][11][14].
• THCa chemistry is destiny: storage and heating can convert acidic cannabinoids into neutral cannabinoids like THC [12].

Common Overstatements to Avoid (And What We Actually Say)

• Overstatement: CBN is a clinically proven sleep aid.
  We say: Specific sleep evidence for CBN remains weak, with no strong validated trial base yet identified [16][17].
• Overstatement: Myrcene is a proven human sedative causing “couch-lock.”
  We say: Myrcene has plausible preclinical bioactivity, but direct human proof is limited [23].
• Overstatement: Terpenes have proven entourage effects in patients.
  We say: Entourage hypotheses are influential, but robust clinical proof remains limited and compound-specific [20][29].
• Overstatement: THCa is always nonpsychoactive.
  We say: THCa itself isn’t psychoactive, but heating and processing convert THCa to THC, changing effective exposure [12].
• Overstatement: Delta-8 THC is safe because it’s hemp-derived.
  We say: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing quality concerns [9]-[11].

Practical Takeaways for Our Formulas

• The most evidence-developed actives are CBD and delta-9 THC.
• Delta-8 THC is not trivial; it’s a psychoactive cannabinoid with less robust safety characterization than delta-9 THC.
• THCa meaningfully changes with processing — interpret raw, gently-handled, and heated formats differently.
• CBG, CBN, and CBC are scientifically credible but clinically immature compared to CBD and THC.
• Listed terpenes likely affect aroma, flavor, and potentially some biologic activity, but compound-specific human therapeutic claims should be made carefully and only where directly supported.

Our Open-Source Formulas: Complete Transparency for Miami County

Traditional RSO came with a recipe. Rick Simpson taught people how to make it. Simpson’s ethos was anti-commercial — give it away free, teach others to make it themselves .

We adapted that ethos for modern legality and safety: we sell a professionally manufactured, lab-tested, standardized product for those who want it, and we publish the complete recipe for those who want to make it themselves.

If you’re in Miami County and $129.99 for our sublingual oil or $49.99 for our vape cartridge isn’t in your budget, you can source the individual cannabinoid distillates and make your own version using our exact specifications below. This is our promise to accessibility, especially for rural Kansas where economic challenges are real.

CBD Golden Paste Recipe for Pets (Our Original Open-Source Formula)

Before we ever published our RSO formula, we published the CBD golden paste recipe that saved Bentley’s life — free for any pet owner facing similar crisis.

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1 to 2 teaspoons freshly ground black pepper (important for absorption)
• CBD oil (dosage depends on pet size and needs; consult veterinarian)

Instructions:

1. Mix turmeric and water in saucepan over low heat, stirring continuously until thick paste forms (7-10 minutes). Add more water if too thick.
2. Add coconut oil and black pepper. Stir until thoroughly mixed.
3. Cool, transfer to jar with lid, refrigerate up to two weeks.
4. Add CBD oil to paste before giving to pet. Start low, increase gradually.

Serving: Mix small amount with pet’s food once or twice daily. Monitor changes and consult veterinarian. Always consult vet before starting new supplement regimen.

This recipe — published free, years before our RSO formulas — demonstrates that our open-source pattern is foundational behavior, not marketing strategy.

RSO Sublingual Oil Formula: Complete Specifications

Price: $129.99
Format: 30 mL bottle (1 fl oz) with graduated dropper (0.1 mL increments)
Base: Organic MCT oil
Total Cannabinoids: 16,590 mg (553 mg per mL)
Approximately 40-60 doses per bottle depending on serving size

Cannabinoid	Amount	Per mL
CBD	4,500 mg	150 mg
CBG	3,000 mg	100 mg
Delta-8 THC	6,000 mg	200 mg
THCa	1,500 mg	50 mg
Delta-9 THC	90 mg	3 mg
CBN	750 mg	25 mg
CBC	750 mg	25 mg

Live Terpenes: 5% by weight
Terpene Profile: Limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene (as detailed above)

Pharmacokinetics:

• Onset: 15-45 minutes (sublingual absorption through oral mucosa)
• Peak effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19% (sublingual route partially bypasses first-pass liver metabolism) [14]

Legal for Kansas: Contains less than 0.3% delta-9 THC (90 mg total in 30 mL bottle). Hemp-derived. Farm Bill compliant.

RSO Vape Cartridge Formula: Complete Specifications

Price: $49.99
Format: 1-gram cartridge
510-thread universal battery compatibility

Cannabinoid	Percentage	Approximate mg
CBD	30%	300 mg
CBG	20%	200 mg
Delta-8 THC	15%	150 mg
THCa	10%	100 mg
CBN	10%	100 mg
CBC	10%	100 mg
Total Cannabinoids	95%	900+ mg

Live Terpenes: 5%+ by weight (same seven-terpene profile as sublingual oil)

Pharmacokinetics:

• Onset: 1-2 minutes (fastest cannabinoid delivery method)
• Peak effects: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35% (variable by inhalation technique) [14]
• Auto-decarboxylation: At 400-450°F vaping temperature, THCa instantly converts to delta-9 THC

Legal for Kansas: Hemp-derived, Farm Bill compliant. Each cartridge contains minimal delta-9 THC at point of sale; THCa converts during vaping per customer action.

When to Use Each Format: Practical Guidance

Use Case	Recommended Format	Why It Works
Fast relief (acute pain, nausea, panic)	Vape cartridge	1-2 minute onset for breakthrough symptoms
Sustained relief (chronic pain, sleep maintenance)	Sublingual oil	4-6 hour duration for all-day coverage
Maximum bioavailability	Sublingual oil	13-19% absorption via oral mucosa
Portability & discretion	Vape cartridge	Compact, no measuring required
Precise dosing control	Sublingual oil	Graduated dropper in 0.1 mL increments
Daytime non-psychoactive use	Sublingual oil (raw, no heat)	THCa stays inactive, zero impairment
Nighttime psychoactive use	Sublingual oil (decarbed) or vape	Activated THCa + delta-8 THC for full potency

Condition-Specific Usage Context for Miami County

Important Disclaimer: The following contexts are informed by cannabinoid research cited throughout this guide. They are not medical prescriptions, not FDA-approved treatment protocols, and not substitutes for professional medical care. These products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have medical conditions, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

For Miami County residents, this is especially critical — when the nearest Level I trauma center is at least an hour away in Kansas City, safety and responsible use aren’t optional.

Chemotherapy-Related Nausea and Appetite Support

Pre-chemo: 0.5-1.0 mL sublingual approximately 1 hour before treatment (delivers 277-553 mg total cannabinoids, including delta-8 THC with antiemetic evidence [9]).

Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset, bypasses digestive system entirely) [14].

Post-chemo: 0.5 mL sublingual every 6 hours as needed for ongoing nausea control [9][13].

Sleep support during treatment: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN for sleep architecture, though evidence is limited [16][17]).

Chronic Pain (Arthritis, Neuropathy, Fibromyalgia)

Daytime functional relief: 0.3-0.5 mL raw sublingual (no heat) — provides anti-inflammatory cannabinoid exposure without psychoactive impairment. Critical for Miami County residents who operate farm equipment, drive tractors, or work in manufacturing where impairment could be dangerous.

Nighttime relief: 0.5-1.0 mL decarboxylated sublingual before bed — combines pain relief with CBN for sleep support [4][13][16].

Breakthrough pain: Vape as needed for rapid-onset relief when pain spikes unexpectedly.

Evidence context: CBD pain evidence [4], delta-9 THC pain evidence [13], caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12].

Sleep Support for Miami County’s Insomniacs

Before bed: 1.0-2.0 mL sublingual oil.

At 2.0 mL: Delivers 50 mg CBN — the dosage level investigated in 2024 sleep literature (though evidence quality remains limited) [16][17].

At 1.0 mL: Delivers 25 mg CBN — above 20 mg threshold associated with reduced sleep disturbance in some research [16].

Evidence context: CBN sleep literature is weak but suggestive [16][17]. Cannabis and sleep reviews emphasize need for better trials [17]. For Miami County residents whose sleep is disrupted by chronic pain, PTSD, or caregiving stress, CBN may help — but manage expectations.

Anxiety and Stress (Including PTSD)

Daytime functional relief: 0.3 mL raw sublingual (no heat). CBD and CBG address anxiety pathways without psychoactive impairment [3][7].

Nighttime: 1.0 mL sublingual — full profile including CBN for sleep architecture [16].

Evidence context: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage effect [20].

For Miami County veterans: We know Miami County has strong veteran representation from Fort Leavenworth and other military connections. Colin’s personal PTSD story and benzo withdrawal experience speaks directly to veterans who’ve been failed by pharmaceutical approaches. The Asshole Peach product in our broader portfolio is particularly favored by veterans for pain and PTSD relief.

General Titration Principle: Start Low, Go Slow

Begin with 0.25-0.5 mL sublingual (138-277 mg total cannabinoids). Assess effects over 2-3 hours before increasing.

Individual variation depends on body weight, metabolism, tolerance, concurrent medications, and genetics. What works for your neighbor in Osawatomie may not work for you in Paola.

For Kansas-specific considerations: If you’re taking blood thinners (common in rural populations with cardiovascular disease), SSRIs, or have liver concerns (given Kansas’s higher rates of metabolic syndrome), start even lower and consult your healthcare provider about potential interactions [6].

Delivery and Access for Miami County, Kansas

Houston Same-Day Delivery Zones (For Context)

We operate the only same-day RSO delivery system in Houston. While this doesn’t directly serve Miami County, it demonstrates our operational capability:

Zone	Coverage	Delivery Fee	Turnaround
Texas Medical Center (TMC)	MD Anderson, Memorial Hermann, Methodist, Texas Children’s, St. Luke’s, 60+ institutions	FREE	2-4 hours
Inner Loop (610)	Downtown, Midtown, Montrose, Heights, Rice Village, Museum District, River Oaks, Galleria	$5	2-4 hours
Within Beltway 8	Bellaire, Memorial, Spring Branch, South Houston, Pasadena, Hobby Airport	$10	3-5 hours
Greater Houston suburbs	Katy, Sugar Land, Pearland, Clear Lake, Woodlands, Cypress, Tomball, Humble	$15	4-6 hours

The TMC free delivery matters because it’s the world’s largest medical complex with 10+ million patient visits annually. We built infrastructure to serve the sickest patients immediately. For Miami County residents who must travel to Kansas City or Topeka for oncology care, this level of service orientation should tell you how seriously we take patient access.

Nationwide Shipping to Miami County

How we reach you in Kansas:

• All 50 states where Farm Bill-compliant products are legal (Kansas included)
• USPS Priority Mail: 2-3 business days
• FedEx/UPS Ground: 3-5 business days
• Discreet packaging with no cannabis branding visible (important for rural mailbox privacy)
• Tracking provided for all orders
• Temperature-stable packaging for summer shipments (Kansas summers hit 100°F; we protect product integrity)
• Signature-required option available

For Miami County’s rural routes: We understand your mail carrier and know how packages arrive at the end of a long gravel driveway. We package to withstand the journey.

International Shipping (If Needed)

We ship internationally to jurisdictions where hemp-derived products with <0.3% delta-9 THC are permitted. If you’re a Miami County resident with family overseas facing cancer or chronic pain, we can potentially serve them.

International orders include:

• Full documentation for customs
• Certificates of Analysis (COAs)
• Detailed receipts
• Customer accepts all customs and legal responsibility

Our PANDEM1C SEO Technology

Our proprietary system has 14 million distinct geopolitical locations in its database with over 300 AI models, driving organic search visibility across six continents. For Miami County residents searching “RSO Kansas,” “legal cannabis oil Miami County KS,” “RSO for pain Kansas,” “THCa oil Kansas,” or “buy RSO online Kansas,” you’re finding us because our technology ensures discoverability while maintaining content integrity.

How to Order: Step-by-Step for Miami County Residents

1. Visit our website: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/
2. Verify age: 21+ required (Kansas legal standard for hemp products)
3. Select product: Sublingual oil ($129.99) or vape cartridge ($49.99)
4. Add to cart: Continue shopping or checkout
5. Enter shipping address: Your Miami County address (Paola, Osawatomie, Louisburg, or rural route)
6. Select shipping: USPS Priority (2-3 days) or FedEx/UPS Ground (3-5 days)
7. Payment: Secure checkout
8. Receive confirmation: Email with tracking
9. Package arrival: Discreet box at your door
10. COA access: Request via email or download from website for your records

Questions? Call (832) 416-2816 or email [email protected]

Business hours:

• Monday-Thursday: 10:00 AM – 7:00 PM
• Friday-Saturday: 10:00 AM – 10:00 PM
• Sunday: 10:00 AM – 4:00 PM

Competitive Comparison: OilWell RSO vs. Alternatives

OilWell RSO vs. Medical Marijuana Dispensaries (e.g., Kansas Adjacent States)

Dimension	Medical Marijuana RSO	OilWell RSO for Miami County
Cannabinoid profile	Typically THC-only or limited blend	7 cannabinoids: CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC
CBG content	Usually 0 mg	3,000 mg
CBN content	Usually 0 mg	750 mg
CBC content	Usually 0 mg	750 mg
Patient-controlled potency	No — always fully psychoactive	Yes — THCa non-psychoactive until you heat it
Access requirements	Medical card required (not available in Kansas)	Age 21+ only, no medical card needed
Qualifying conditions	Cancer, PTSD, terminal illness, etc.	None required — any adult 21+ can purchase
Delivery	Must travel to dispensary (Colorado, Oklahoma)	Ships directly to your Miami County door
Legal for Kansas	No — Schedule I under Kansas law	Yes — Farm Bill compliant hemp product

OilWell RSO vs. Hemp CBD Oils (e.g., Lazarus Naturals)

Dimension	Lazarus Naturals RSO (10 mL, 1,000 mg)	OilWell RSO (30 mL, 16,590 mg)
Total cannabinoids	1,000 mg	16,590 mg (16.6x more)
CBD content	~950 mg	4,500 mg
CBG content	15.5 mg	3,000 mg (193x more)
CBN content	0.7 mg	750 mg (1,071x more)
Delta-8 THC	0 mg	6,000 mg
THCa convertible to delta-9 THC	Minimal	1,500 mg (converts to ~1,315 mg delta-9 THC)
Psychoactive option	No meaningful effect	Yes — via THCa decarboxylation and delta-8 THC
Approximate price	$40-50	$129.99 (more total cannabinoids per dollar)

For Miami County residents: If you’ve tried CBD oil from the health food store in Paola and didn’t get results, it’s not because cannabinoids don’t work. It’s because you need a multi-cannabinoid approach at therapeutic doses.

Our Broader Product Portfolio

Beyond RSO, we produce a range of cannabinoid products developed from Colin’s formulation knowledge:

Asshole Peach — Our most popular product. These peach gummy rings deliver 268 mg total cannabinoids per ring (28 mg Delta-9 THC, 50 mg Delta-8 THC, 20 mg Delta-10 THC, 20 mg THCo, 100 mg CBD, 50 mg CBG). Favored by veterans for PTSD and pain relief. Price: $39.99

Peace Gummies — Developed from Colin’s personal benzo withdrawal experience. Each peach delivers 320 mg total cannabinoids (30 mg CBN, 15 mg Delta-9 THC, 25 mg Delta-8 THC, 100 mg CBD, 150 mg CBG). Also available in vape form for quick relief, which Colin personally uses for insomnia and severe PTSD. Price: $34.99

SWEETEMintz — Sugar-free vegan peppermint hard candy with 28 mg Delta-9 Nano THC, 100 mg Nano CBD, 50 mg CBG Isolate. Zero sugar, diabetic-friendly. Price: $39.99

Custom creations — We design tailored products on request: specific cannabinoid ratios, delivery formats, vegan formulations, diabetic-friendly options. For Miami County residents with unique health needs, this is access to pharmaceutical-style customization without the pharmaceutical gatekeeping.

Safety and Legal Compliance for Kansas

Age requirement: 21+ for all RSO products.

THC content compliance: All products contain less than 0.3% delta-9 THC by dry weight at point of sale. Hemp-derived. Farm Bill compliant. Legal under federal law and Kansas state law (Kansas Senate Bill 263, the Alternative Crop Research Act, allows hemp products with <0.3% delta-9 THC).

FDA disclaimers: Not evaluated by FDA. Not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Consult healthcare provider before use.

Safety warnings: May cause drowsiness or impairment. Do not operate vehicles or machinery. Consult physician if pregnant or nursing. Keep out of reach of children. For Kansas residents working in agriculture or manufacturing, impairment warnings are especially critical.

Legal responsibility: Buyer responsibility to verify local laws. We assume no legal responsibility for customer’s use or decarboxylation decisions. Void where prohibited.

Drug testing: THCa stays non-psychoactive when raw and should not trigger standard drug screens. Delta-8 THC and activated (decarboxylated) delta-9 THC will trigger positive results. Be honest with employers. If you work for a Kansas employer with zero-tolerance policies, use the raw THCa option or understand the risks.

Storage: Keep in cool, dark place. Kansas summers are hot. Refrigeration extends shelf life. THCa can slowly decarboxylate over time at room temperature; refrigeration preserves acidic form.

Conclusion: Why OilWell for Miami County

Miami County, Kansas is not Houston, Texas. You have different challenges, different distances to healthcare, different economic pressures, and different community values. But you share the same fundamental need: honest medicine that works, transparent information you can verify, and a company that cares more about people than profits.

Here’s what we offer that no one else does:

1. Complete formula transparency — Every mg, every percentage, every terpene. If you can’t afford our product, you can make it yourself using our published recipe. That’s the Rick Simpson ethos adapted for modern legality and safety.

2. Patient-controlled potency — Use THCa raw for daytime relief without impairment. Decarboxylate at home for full psychoactive potency. Kansas law allows you to control your medicine after purchase.

3. Seven cannabinoids, not one — Traditional RSO was just THC. Our formula includes CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC because a decade of formulation work taught us that single cannabinoids are not enough for complex conditions.

4. Lab-tested safety — No residual solvents. No pesticides. Heavy metals below FDA limits. Microbial screening. COAs available. For Miami County residents who can’t afford to take health risks, this matters.

5. Nationwide shipping to your door — No driving to Colorado or Oklahoma dispensaries. No medical card required (Kansas doesn’t have a medical program anyway). Order from your home in Paola or Louisburg and receive within 2-5 business days.

6. Evidence-based education — 29 peer-reviewed citations. Honest evaluation of what each compound can and cannot do. No snake oil. No hype. Just the science as it stands, with all its limitations clearly stated.

7. Real founder story — Colin didn’t start from privilege. He started from border violence, PTSD, benzo addiction, and a paralyzed dog he refused to euthanize. Every product is formulated from lived experience, not market research.

8. Media validation — Seven features on Houston’s ABC13 over four years. Five different reporters. Independence that can’t be bought.

For Miami County’s veterans: Colin is one of you. He used cannabinoids to quit Xanax cold turkey. He uses the same vape formula we sell to manage his PTSD and insomnia. Asshole Peach was developed for veteran pain and trauma. The Peace Gummies vape formula is his personal nighttime medicine. You’re not buying from a corporation — you’re buying from someone who has walked the path.

For Miami County’s cancer patients: We won’t tell you RSO cures cancer, because it doesn’t. The preclinical evidence is interesting , but no human trial has proven cancer cure . What we will tell you is that our formula contains cannabinoids with anti-inflammatory properties, anti-nausea support for chemo [9][13], potential sleep aid during treatment [16][17], and appetite support [1]. Use it alongside your oncologist’s care, not instead of it.

For Miami County’s chronic pain sufferers: Whether it’s arthritis from decades of physical work, neuropathy from diabetes, or fibromyalgia that the pain clinic in Kansas City can’t seem to treat, our multi-cannabinoid approach targets multiple pain pathways simultaneously [4][12][13][24]. The raw THCa option lets you function during the day. The decarbed option gives you relief at night.

For Miami County’s economically strained: We published our formula. If $129.99 is out of reach economically (and we understand that it is for many), source the individual distillates and make it yourself. We’ll even help you find suppliers. Simpson gave his oil away; we can’t give ours away for free and stay in business, but we can give you the recipe. That’s our commitment to accessibility.

For Miami County’s skeptics: We don’t ask you to believe us because we say so. Believe the 29 peer-reviewed citations. Believe ABC13’s seven features. Believe the Certificates of Analysis. Believe the fact that we’re DSHS licensed, have a near-5.0 Google rating, and have been operating since 2019. Believe that no one else publishes their complete formula — and ask yourself why.

How to Get Started Today

Order online: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/

Call us: (832) 416-2816 (Monday-Sunday, 10 AM – varying close times)

Email: [email protected]

Visit our Houston location: 810 Richmond Avenue, Houston, TX 77006 (Montrose neighborhood) — if you’re ever in Houston for MD Anderson treatment or other medical care, stop by.

Ship to your Miami County address: USPS Priority Mail will have it to you in 2-3 business days. Use the signature-required option if you’re concerned about mailbox security on rural routes.

Questions about drug testing? Call us. We’ll explain exactly how THCa, delta-8 THC, and delta-9 THC interact with workplace screens.

Questions about decarboxylation? Call us. We’ll walk you through the process step-by-step.

Questions about our formula? Everything is published right here. Every mg. Every terpene. Every citation.

Miami County, Kansas deserves the same access to honest cannabinoid medicine that Houston has. The law allows it. The science supports it. We’ve built it. And we’re shipping it to your door.

This is more than a brand. This is a promise: integrity, creativity, and the mission that started when Bentley got up, walked across the room, and brought his ball to play.

Order today. Ask questions. We’re here.